Clear cell carcinoma of the ovary (CCCO) is an uncommon, clinically aggressive neoplasm that has a propensity for the development of venous thrombosis and embolization, especially when compared to other subtypes of ovarian malignancies. We present a fatal case of a 59-year-old woman with a clinical course complicated by venous thrombosis and pulmonary thromboembolism that was attributed to CCCO discovered initially at autopsy. C lear cell carcinoma of the ovary (CCCO) is a distinct histopathologic subtype of epithelial ovarian tumors and accounts for <5% of all ovarian malignancies (1) . Most cases of CCCO occur in women in the fourth and fi fth decades of life, and clinical presentation includes a mass usually detected on physical examination or by imaging. Relative to other ovarian neoplasms, CCCO has been more commonly associated with earlier stages and increased risk of venous thrombosis (2) . We present the clinical, pathologic, and autopsy fi ndings of a fatal case of a clinically undiagnosed CCCO discovered at autopsy associated with deep vein thrombosis and pulmonary thromboemboli.
CASE PRESENTATION
A 59-year-old white woman with prior hypertension, hyperlipidemia, and depression developed bilateral deep vein thrombosis (DVT) and bilateral pulmonary thromboembolism. An inferior vena cava fi lter was placed and warfarin therapy begun. Several weeks later, she presented to the emergency department at Baylor Regional Medical Center at Grapevine with pain, swelling, and a markedly swollen and discolored left lower extremity with mottling at the lateral aspect. On admission, her hemoglobin was 7.6 g/dL; hematocrit, 26%; white blood cell count, 9.8 K/uL; blood urea nitrogen, 40 mg/ dL; creatinine, 1.6 mg/dL; prothrombin time, 37.2 seconds (reference range 9.0-12.0 seconds); and international normalized ratio, 3.6. Computed tomography disclosed a 19.2 × 12.3 × 10.8 cm mass in the pelvis consistent with multiple large uterine fi broids with areas of heterogeneity and cystic degeneration. She developed acute respiratory failure and hypotension. An echocardiogram found an ejection fraction of 25%. Despite adequate anticoagulation, her DVT persisted, and she eventually developed DVT in her peripherally inserted central catheter. She progressed to multisystem organ dysfunction and died 2 days later.
Autopsy disclosed a 38.0 × 19.5 cm area of red-purple discoloration with epidermal sloughing that extended from the left leg to the medial aspect of the left thigh. Th e distal portion of the left foot had an area of sloughing and purple discoloration of all digits. Th ere were bilateral ovarian masses measuring 9.5 cm and 15.0 cm on the right and left sides, respectively (Figure 1) . Th e cut surface of both masses showed white-tan solid nodules with occasional cystic spaces containing brown-yellow fl uid. Th ere were multiple intramural, tan-white, whorled, well-circumscribed nodules, ranging up to 2.0 cm in diameter within the myometrium of the uterus. Multiple intravascular thromboemboli were found in the left lung hilum and in the right and left lower lobes. Th e left lower lobe had two well-demarcated areas of dark red, hemorrhagic induration in the periphery (5.0-7.0 cm). Leg dissection revealed thrombi in the deep leg veins bilaterally. Th rombotic material was adherent to the inferior vena cava fi lter.
Microscopically, the ovaries were composed of nests and sheets of tumor cells with eccentrically located angulated nuclei, clear cytoplasm, and focal hobnail patterns (Figure 2 ). Also present were areas of necrosis and hemorrhage. Sections from bilateral deep leg veins showed laminated thromboemboli with organization into the endothelial wall. Organizing intravascular thromboemboli with surrounding areas of parenchymal hemorrhagic necrosis were found in both lungs.
DISCUSSION
In 2003, the World Health Organization described CCCO as being composed of clear cells, growing in a solid, tubulocystic, or papillary pattern, with hobnail cells lining tubules and cysts (3) . Patients usually present in their fourth to fi fth decade of life with a pelvic mass ranging in size from 3.0 to 20.0 cm, and most cases are detected preoperatively either by physical examination or radiographic imaging (4). Women with CCCO present at a younger age and an earlier stage relative to other epithelial ovarian carcinomas (5) . Treatment includes surgery and chemotherapy, but prognosis in advanced stages is generally dismal, especially when compared with other subtypes of epithelial ovarian neoplasms (6) . CCCO has been associated with hypercalcemia (2) and endometriosis, and some authors suggest that atypical endometriosis may be a precursor lesion (7, 8) .
CCCO is more commonly associated with development of venous thromboembolic events when compared to other subtypes of epithelial ovarian tumors (9, 10) . In a study performed by Duska et al, venous thromboembolic events occurred in 42% of patients with CCCO, which was two times the rate found in matched non-CCCO controls with epithelial ovarian carcinomas of other histologies (9) .
In 1865, Trousseau fi rst described the association between malignant diseases and thromboembolic events (11). Hypercoagulability is often seen in concurrence with malignancy, and the overall incidence varies from 1% to 11% (12, 13) . DVT as a postoperative complication of gynecologic surgeries has also been chronicled (14, 15) .
Th e development of venous thrombosis is caused by alterations to one or more components of Virchow's triad, which consists of stasis, damage to the vascular endothelium, and hypercoagulable states. Stasis is often due to various causes of immobility (16, 17) . Hypercoagulable states include a myriad of acquired and inherited conditions such as protein C and S defi ciencies, antithrombin III defi ciency, factor V Leiden, pregnancy, oral contraceptive use, and malignancy (16, 18, 19) . Endothelial damage often occurs because of recent trauma or surgery (16, 18) . Anatomically, it is reasonable to deduce that the large, bilateral pelvic masses compressed the pelvic veins, which resulted in blood stasis and thrombosis leading to DVT and pulmonary embolism; however, a hypercoagulable state due to this tumor may have also contributed to the death of this patient.
It is important to recognize the association between CCCO and the development of venous thromboemboli, as it has been suggested that these patients receive anticoagulation therapy indefi nitely after surgery since there is a high rate of venous thromboembolism after surgery (9) .
Although venous thrombosis and pulmonary thromboembolism may be present at the time of ovarian cancer diagnosis, this case is unusual, in our experience, since the patient died before a cancer diagnosis was established. Clear cell carcinoma of the ovary associated with increased risk of venous thrombosis
